九芝堂：公司将及时履行信息披露义务

Core Viewpoint - The company, Jiuzhitang, acknowledges the inherent uncertainties in drug development, particularly regarding the lengthy and complex process from clinical trials to market launch, which can be influenced by unpredictable factors [1] Group 1: Drug Development Process - The drug development cycle is characterized by a long duration and multiple stages, making it susceptible to various unpredictable factors [1] - Clinical trial progress and outcomes are subject to significant uncertainty, which can impact the overall timeline and success of product launches [1] Group 2: Market Competition - Future market competition for products remains uncertain, adding another layer of risk to the company's drug development efforts [1] - The company emphasizes the importance of monitoring developments and fulfilling information disclosure obligations to keep investors informed [1]